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Objectives: Schizophrenia (SZ) is complex and multifactorial neuropsychiatric 
disorder.Schizophrenia is estimated to have the highest genetic and environ-
mental loads and penetrance among the neurocognitive disorders. The essential 
role dopamine D2 receptor (DRD2) in dopamine signalling, DRD2 gene has been 
regarded as one of the top candidate genes for SZ. The intention of this study was 
to evaluate the chromosomal aberrations as well as disruption in the DRD2 gene 
among the SZ patients. MethOds: As a preliminary measure in the search for the 
chromosomal abnormalities of a gene or genes relevant to this illness, cytogenetic 
and molecular screenings using the Peripheral blood Lymphocyte of 45 SZ patients 
were obtained. Each patient were diagnosed by a neuropsychiatric professionals 
based on both DSM-IV(TR) and SCID questionnaire. Equal numbers of healthy 
controls were also analysed. Results: In our study random numerical and struc-
tural aberrations were detected in chromosomes 6, 11, 15, 16 and 22 (15q13.3 and 
22q11.2). In this study the comparison between the cases and control for the 
numerical as well as structural mutations showed a degree of (P< 0.001) which 
was more in cases compared to control. Structural aberrations predominantly 
observed were deletions and micro-deletions of 22q11.2 and 15q13.3. Further, 
the disruption in the DRD2 gene which resulted into polymorphism was seen in 
SZ patients while compared to healthy controls. cOnclusiOns: In conclusion, 
our cohort study supports the hypothesis suggesting that a chromosomal abnor-
mality as well as disruption in DRD2 gene is contributing to SZ pathogenesis. 
On the contrary, genetics stimulate to rethink SZ from a neurological as well as 
biological viewpoint and also to understand the phenotypes of these disorder in 
terms of biological pathways. Key words: Schizophrenia, DRD2 gene, chromosomal 
abnormalities
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Objectives: Melanoma is the fifth most common cancer in the UK, accounting for 
4% of all new cases of skin cancer. In 2011, 13,300 cases of malignant melanoma 
were diagnosed in the UK, out of which 2,200 people died from the disease. This 
systematic review evaluates the clinical effectiveness of VivaScope (MAVIG GmbH, 
Munich), a non-invasive reflectance confocal microscope (RCM), used following der-
moscopy for the diagnosis of melanoma. This research was conducted as part of 
a National Institute for Health and Care Excellence (NICE) Diagnostic Assessment 
Report on VivaScope. MethOds: Electronic databases (MEDLINE, EMBASE and the 
Cochrane Library) were searched in October 2014 and updated in February 2015 to 
identify studies evaluating RCM following dermoscopy with histopathology as the 
reference standard in detecting malignant melanoma. Researchers were contacted 
for additional information on studies identified. Clinical experts were contacted 
for details on any unpublished studies. Results: Of the 7,446 studies identified 
in the literature search, 10 were considered relevant to this review. However, none 
were conducted in the UK (1 Spain, 1 China, 1 Australia, 2 Brazil/USA, 2 Australia/
Italy, 3 Italy) and the studies were considered too heterogeneous (e.g. differences in 
study design, patient/lesion level data, with/without comparator) for their results 
to be combined in a meta-analysis. Overall results indicate that RCM subsequent 
to dermoscopy may improve diagnostic accuracy of malignant melanomas com-
pared to dermoscopy alone. One study (Alarcon et al. 2014) was deemed to be most 
representative of UK clinical practice and reported statistically significant dif-
ferences in sensitivity (97.8% vs 94.6%, p= 0.043) and specificity (92.4% vs 26.74%, 
p< 0.000001), for VivaScope 1500 following dermoscopy compared with dermoscopy 
alone. cOnclusiOns: VivaScope following dermoscopy may increase the accuracy 
of a diagnosis of malignant melanoma compared to dermoscopy alone. However, 
the absence of UK studies makes the generalisability of the results to UK clinical 
practice unclear.
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Objectives: HPV genotypes 16/18 are the most prevalent worldwide and are 
present in around 70% of all cervical cancer (CxCa) cases. This analysis aims to 
estimate clinical and economic impact of the implementation of HPV 16/18 geno-
typing test for CxCa primary screening at Mexican Institute of Social Security 
(IMSS) that is the main healthcare provider covering around 50% of Mexican 
population. MethOds: A cohort Markov model with a five-year time horizon 
was developed. A 300,000 women cohort was simulated since payer perspective. 
Two scenarios were evaluated: 1) cytology screening, where women are re-tested 
for ASCUS, ≥ CIN1 are referred to colposcopy, cycle lenght is 1-year, if negative 
3 consecutive cycles length changes to 2-years; 2) primary screening HPV gen-
otyping, women HPV-16/18 are referred to colposcopy, other 12 high-risk HVP 
genotyping are referred to cytology with 12-months follow-up, and when nega-
tive a follow-up in 3-year cycle. Clinical and test performance data were taken 
from ATHENA trial and other published sources. Direct medical costs for cytol-
ogy and CxCa treatments were obtained from local published sources. Costs for 
HPV genotyping test was given by the manufacturer. Costs are expressed in 2015 
USD ($1USD= $15MXN). Results: Due to cobas HPV genotyping sensibility, total 
number of CxCa cases would be 46% lower (221 vs 409, respectively) and would 
result in 44% less mortality events (8 vs 15, respectively) compared to cytology. To 
informatics, and Discrete Event Simulation (DES) known in operations research, 
for modeling todays complex and personalized treatment decisions over time, 
involving multiple interactions and decision gates. MethOds: The usefulness of 
both modeling techniques was assessed in a case study on the treatment of meta-
static Castration Resistant Prostate Cancer (mCRPC) in which Circulating Tumor 
Cells (CTC) may be used as a response marker for switching first to second line 
treatment. Techniques were compared on user-friendliness, input requirements, 
input possibilities, model checking facilities, and results. Input parameters were 
similar for both models, consisting of costs, QoL, treatment effectiveness, diag-
nostic performance, physicians’ behavior and survival. Primary outcome meas-
ures were health outcomes, expressed in QALYs, and costs. Results: Modelling 
was considered easier using TA, as this approach allows independent modeling 
of the actors and elements comprising the treatment process, such as patients, 
physicians, tests and treatments, and their mutual interaction and communica-
tion. Furthermore, the statistical model checking feature in the TA software was 
found to be a powerful tool for validation. Input requirements and possibilities 
were similar for both modelling approaches in this case study. Both modelling 
approaches yield comparable results. Using TA, CTC reduced first and second line 
treatment by, on average, 108.9 and 107.6 days, respectively. Using DES, treatment 
was reduced by 83.6 and 85.0 days. CTC therefore reduced healthcare costs by 
€ 28,998 and € 21,992 according to TA and DES, respectively. cOnclusiOns: Both 
Timed Automata and Discrete Event Simulation seem to be suitable for mod-
eling complex and personalized treatment processes like that of mCRPC. Timed 
Automata is a new and interesting alternative modeling technique, as it allows 
explicit separation of model components and supports statistical model checking 
to validate models.
ReseARCh PosteR PResentAtions – session i
heAlth CARe tReAtMent stUDies
MeDiCAl DeViCe/DiAgnostiCs – Clinical outcomes studies
PMD1
systeMAtiC ReView oF theRMAl MAssAge theRAPy FoR the tReAtMent 
oF DRy eye synDRoMe
Lee J
National Evidence-based Healthcare Collaborating Agency (NECA), Seoul, South Korea
Objectives: The safety and effectiveness of Thermal Massage Therapy for the 
Treatment of Dry Eye Syndrome as a technology for treatment of dry eye symptom 
by stimulation of the obstructed meibomian glands through application of heat and 
vibration to the areas around the eyelids and the eyes were assessed. MethOds: 
For information search for systematic review considerations on Thermal Massage 
Therapy for the Treatment of Dry Eye Syndrome, 8 domestic databases including 
Korea Med and overseas databases including Ovid-Medline, Ovid-Embase and 
Cochrane Library were used. A total of 107 literatures were searched through search 
strategy. As the result, a total of 3 domestic and overseas literatures were included 
in the final assessment by applying the criteria for selection and exclusion to the 74 
literatures after having excluded 33 overlappingly searched literatures. Each of the 
stages from literature search to application of selection standards and extraction 
of data were carried out independently by 2 assessors under the deliberation by the 
Sub-committee. Tools of Scottish Intercollegiate Guidelines Network (SIGN) were 
used for assessment of the quality of literature. Results: Regarding the safety of 
the Thermal Massage Therapy for the Treatment of Dry Eye Syndrome, 3 literature 
reported conjunctivitis, temporary visual impairment, headache and abnormal-
ity in the area of contact as the procedure related complications or side effects. 
The effectiveness of the Thermal Massage Therapy for the Treatment of Dry Eye 
Syndrome was assessed by means of the ocular surface disease index (OSDI), break-
up time (BUT), schirmer tear test (STT) and osmotic pressure of tear on the basis of 
3 literatures. cOnclusiOns: Thermal Massage Therapy for the Treatment of Dry 
Eye Syndrome was assessed as a safe and effective technology capable of improv-
ing the dry eye symptom by alleviating the obstructed meibomian glands through 
application of heat and vibration to the areas the eyes.
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Objectives: The objective of this study was to examine the diagnostic accuracy 
of targeted sonomarkers in the first trimester for a simple screening method that 
improves outcome and has a positive cost/benefit ratio. MethOds: We analyzed 23 
sonomarkers from 66 fetuses (6 cases of open spina bifida and 60 normal fetuses) 
to determine the most robust screening marker associated with spina bifida. We 
compared the variables between the two groups using Fisher’s exact test or Mann-
Whitney test. We evaluated the sensitivity with 5% FPR. We also performed receiver 
operating characteristic (ROC) curve analysis to determine which markers were 
significant to propose a simpler test. Results: Some markers showed statistically 
significant differences between the two groups (p< 0.001), but using both likelihood 
ratio and area under the ROC curve analysis, we demonstrated that the subjective 
Dry brain, Crush sign and BPD/AC ratio from axial views and numeric BS/BSOB ratio, 
FMF angle and Cisterna magna from sagittal views were significantly associated 
with the fetal risk of having OSB. cOnclusiOns: Yet, subjective markers are usually 
dependent on the operator’s experience. Contrary, the measurement of the BPD/AC 
ratio or the BS/BSOB ratio at 11-13 weeks is simple and could be easily incorporated 
into the routine scan. If this test accurately predicts open spina bifida in up to 100% 
of cases, it would cost for one diagnostic 200 Ron= 44 Euro vs. the maternal serum 
alpha-fetoprotein test (250 Ron= 55 Euro) or amniocentesis (2000 Ron= 444 Euro) that 
are needed to early diagnosis of open spina bifida.
